Number of employees
5
Description
BioMarker Strategies is a Baltimore, MD-based cancer diagnostics company developing the SnapPath™ live-tumor-cell testing system to improve the treatment of cancer. This novel biomarker testing system, supported by funding from the National Cancer Institute, will enable functional, pathway-based, molecular profiles of solid tumor biopsies to help guide oncology drug treatment decisions that are not possible using current tumor-cell processing methods. BioMarker Strategies 855 N.Wolfe St.
Fact sheet
Products & services
Similar companies nearby
-
Key Technologies, Inc.
Distance: 2.0 Mi40 E. Cross St
21230-5189 Baltimore -
CARDIOMED DEVICE CONSULTANTS, LLC
Distance: 16.1 Mi1327 Bluegrass Way
21054 Gambrills